Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Peter Duerr

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Plos Neglected Tropical Diseases|April 26, 2014
Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinentAnette Stauch, Hans-Peter Duerr, Albert Picado, et al.
Plos Neglected Tropical Diseases|December 6, 2011
Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and controlAnette Stauch, Ram Rup Sarkar, Albert Picado, et al.
Skin Pharmacology and Physiology|February 4, 2016
Relationship between Histological and Clinical Course of Psoriasis: A Pilot Investigation by Reflectance Confocal Microscopy during Goeckerman TreatmentRami Archid, Hans Peter Duerr, Alexa Patzelt, et al.
Retina (Philadelphia, Pa.)|August 23, 2016
EARLY CRT MONITORING USING TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY DOES NOT ADD TO VISUAL ACUITY FOR PREDICTING VISUAL LOSS IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL RANIBIZUMAB: A Secondary Analysis of Trial DataKaty J L Bell, Andrew Hayen, Paul Glasziou, et al.
Scientific Reports|December 17, 2017
Modelling mosquito infection at natural parasite densities identifies drugs targeting EF2, PI4K or ATP4 as key candidates for interrupting malaria transmissionKoen J Dechering, Hans-Peter Duerr, Karin M J Koolen, et al.
Frontiers in Immunology|August 16, 2021
Whole Blood Interferon γ Release Is a More Sensitive Marker of Prior Exposure to <i>Coxiella burnetii</i> Than Are Antibody ResponsesAnja Scholzen, Margot de Vries, Hans-Peter Duerr, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Repurposing isoxazoline veterinary drugs for control of vector-borne human diseasesMarie Miglianico, Maarten Eldering, Hannah Slater, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Plos Neglected Tropical Diseases|April 26, 2014
Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinentAnette Stauch, Hans-Peter Duerr, Albert Picado, et al.
Plos Neglected Tropical Diseases|December 6, 2011
Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and controlAnette Stauch, Ram Rup Sarkar, Albert Picado, et al.
Skin Pharmacology and Physiology|February 4, 2016
Relationship between Histological and Clinical Course of Psoriasis: A Pilot Investigation by Reflectance Confocal Microscopy during Goeckerman TreatmentRami Archid, Hans Peter Duerr, Alexa Patzelt, et al.
Retina (Philadelphia, Pa.)|August 23, 2016
EARLY CRT MONITORING USING TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY DOES NOT ADD TO VISUAL ACUITY FOR PREDICTING VISUAL LOSS IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL RANIBIZUMAB: A Secondary Analysis of Trial DataKaty J L Bell, Andrew Hayen, Paul Glasziou, et al.
Scientific Reports|December 17, 2017
Modelling mosquito infection at natural parasite densities identifies drugs targeting EF2, PI4K or ATP4 as key candidates for interrupting malaria transmissionKoen J Dechering, Hans-Peter Duerr, Karin M J Koolen, et al.
Frontiers in Immunology|August 16, 2021
Whole Blood Interferon γ Release Is a More Sensitive Marker of Prior Exposure to <i>Coxiella burnetii</i> Than Are Antibody ResponsesAnja Scholzen, Margot de Vries, Hans-Peter Duerr, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Repurposing isoxazoline veterinary drugs for control of vector-borne human diseasesMarie Miglianico, Maarten Eldering, Hannah Slater, et al.
Pageof 2